Prescription medication · Statin / Cholesterol Absorption Inhibitor
rosuvastatin/ezetimibe
Also sold as Roszet. This medicine can help lower LDL cholesterol (bad cholesterol) if you have high cholesterol.
Data updated 2026-05-15
- 87,323
- FDA reports
- 12
- InteractionsSeveral interactions
- Rx
- Availability
What the data shows
rosuvastatin/ezetimibe (Roszet) is a prescription Statin / Cholesterol Absorption Inhibitor, with 87,323 FDA adverse-event reports on file, with 12 documented drug interactions.
Reporting volume reflects how widely a drug is used and studied, not how dangerous it is, a FAERS report documents a temporal association, never proof of cause.
rosuvastatin/ezetimibe (Roszet) is a prescription Statin / Cholesterol Absorption Inhibitor. This medicine can help lower LDL cholesterol (bad cholesterol) if you have high cholesterol.
Roszet contains rosuvastatin, which is a statin medicine. It helps lower bad cholesterol and reduce the risk of heart problems.
Verify with FDA → · CMS NADAC pricing →
What it does
This medicine can help lower LDL cholesterol (bad cholesterol) if you have high cholesterol.
Common side effects
Headache, Nausea, Muscle pain
Key warnings
Rosuvastatin can sometimes cause muscle problems, including rhabdomyolysis.
The sections below are summarized in plain English from rosuvastatin/ezetimibe's FDA-approved prescribing information. They describe what the official label says, and are not personal medical advice.
How It Works
Rosuvastatin blocks a substance your body needs to make cholesterol. This lowers the amount of cholesterol in your blood. It helps prevent heart attacks and strokes.
Side Effects (from patient reports)
Based on 87,323 FDA adverse event reports.
Most-reported reactions
Adverse reactions in FAERS for rosuvastatin/ezetimibe, by number of reports
- Tiredness
Tiredness
11,698 reports
- Feeling sick to your stomach
Feeling sick to your stomach
10,037 reports
- Difficulty breathing
Difficulty breathing
9,212 reports
- Loose stools
Loose stools
9,199 reports
- Muscle pain
Muscle pain
8,784 reports
- General pain
General pain
8,419 reports
- Head pain
Head pain
7,798 reports
- Feeling lightheaded
Feeling lightheaded
7,718 reports
- Joint pain
Joint pain
7,254 reports
- Weakness
Weakness
7,204 reports
What this shows Bars show how often each reaction was reported, not how likely it is to happen, a report records a temporal association, never proof that the drug caused it.
Serious Warnings
Rosuvastatin can sometimes cause muscle problems, including rhabdomyolysis. This can damage your kidneys. Tell your doctor right away if you have unexplained muscle pain, tenderness, or weakness, especially if you also have a fever or feel sick. This medicine can also cause liver problems. Your doctor may do blood tests to check your liver.
Known Drug Interactions
Intervention: Sofosbuvir/velpatasvir/voxilaprevir Ledipasvir/sofosbuvir Avoid concomitant use with rosuvastatin. Simeprevir Dasabuvir/ombitasvir/paritaprevir/ritonavir Elbasvir/grazoprevir Sofosbuvir/velpatasvir Glecaprevir/pibrentasvir Atazanavir/ritonavir Lopinavir/ritonavir Initiate with rosuvastatin 5 mg once daily, and do not exceed a dose of rosuvastatin 10 mg once daily.
Mechanism: This antiviral medicine increases the amount of rosuvastatin in your system by changing how your body processes it. Higher levels of the drug can increase the risk of muscle damage.
Simeprevir Dasabuvir/ombitasvir/paritaprevir/ritonavir Elbasvir/grazoprevir Sofosbuvir/velpatasvir Glecaprevir/pibrentasvir Atazanavir/ritonavir Lopinavir/ritonavir Initiate with rosuvastatin 5 mg once daily, and do not exceed a dose of rosuvastatin 10 mg once daily.
Mechanism: These hepatitis C drugs block the pathways your body uses to remove rosuvastatin, leading to higher levels of the statin in your blood. This can increase your risk for serious side effects.
Febuxostat Clinical Impact: Febuxostat increased rosuvastatin exposure more than 1.9-fold. Intervention: In patients taking febuxostat, do not exceed a dose of rosuvastatin 20 mg once daily.
Mechanism: Febuxostat interferes with the way your body handles rosuvastatin, which can nearly double the amount of the drug in your bloodstream. This buildup increases the chance of experiencing harmful side effects.
7 DRUG INTERACTIONS See full prescribing information for details regarding concomitant use of rosuvastatin with other drugs that increase the risk of myopathy and rhabdomyolysis. ( 7.1 ) Aluminum and Magnesium Hydroxide Combination Antacids : Administer rosuvastatin at least 2 hours before the antacid. ( 7.2 ) Warfarin : Obtain INR prior to starting rosuvastatin.
Mechanism: Antacids can stop your body from properly absorbing rosuvastatin if they are taken too close together.
Table 5: Drug Interactions that Increase the Risk of Myopathy and Rhabdomyolysis with Rosuvastatin Cyclosporine Clinical Impact: Cyclosporine increased rosuvastatin exposure 7-fold. The risk of myopathy and rhabdomyolysis is increased with concomitant use of cyclosporine or gemfibrozil with rosuvastatin.
Mechanism: Cyclosporine causes rosuvastatin levels to rise significantly, which increases the danger of severe muscle damage.
This is a plain-language summary of FDA-label interaction records and does not provide individual medication-combination directions.
Common Questions
Can I take Roszet with food?
What should I do if I have muscle pain?
Can I drink alcohol while taking Roszet?
How long will I need to take Roszet?
Will I need blood tests while taking Roszet?
Can I stop taking Roszet if my cholesterol is better?
What if I am Asian?
Can I take antacids with Roszet?
What happens if I have kidney problems?
What are the different strengths of Roszet?
What are the common side effects of rosuvastatin/ezetimibe?
Does rosuvastatin/ezetimibe interact with other medications?
What drug class is rosuvastatin/ezetimibe?
What pregnancy or breastfeeding source fields are listed for rosuvastatin/ezetimibe?
Related Medications in Statin / Cholesterol Absorption Inhibitor
Other drugs grouped near rosuvastatin/ezetimibe - same-class peers and common alternatives.
alirocumab
Praluent
Praluent is a medicine that can lower cholesterol.
Compare with rosuvastatin/ezetimibe →
atorvastatin
Lipitor
Atorvastatin is a drug that lowers cholesterol and reduces the risk of heart problems and stroke.
Compare with rosuvastatin/ezetimibe →
bempedoic acid
Nexletol
Compare with rosuvastatin/ezetimibe →
bempedoic acid/ezetimibe
Nexlizet
Nexlizet is a combination medicine that helps lower cholesterol.
Compare with rosuvastatin/ezetimibe →
cholestyramine
Questran
Cholestyramine is a medicine that helps lower high cholesterol levels in your blood.
Compare with rosuvastatin/ezetimibe →
Medication Guides
Understanding Drug Interactions
How CYP450 enzymes, inhibitors, and inducers affect your medications
Generic vs Brand Name Drugs
FDA requirements, cost savings, and when the difference matters
Narrow Therapeutic Index Drugs
FDA bioequivalence and label-record context for narrow therapeutic index medicines
Common Drug Interactions
Dangerous medication combinations and how to protect yourself
Save on rosuvastatin/ezetimibe
Compare prices and find discounts at pharmacies near you. Free coupons can save up to 80% on prescriptions.
Disclosure: This link may earn us a commission at no extra cost to you. See our terms.
What the FDA Data Shows for rosuvastatin/ezetimibe
The FDA label for rosuvastatin/ezetimibe (sold under brand names such as Roszet) classifies it as a prescription-only medication in the Statin / Cholesterol Absorption Inhibitor class. This medicine can help lower LDL cholesterol (bad cholesterol) if you have high cholesterol. Official labeling lists 5 commonly reported side effects, including Headache, Nausea, Muscle pain.
Post-market surveillance from the FDA Adverse Event Reporting System (FAERS) captures real-world experience. For this drug, FAERS contains 87,323 voluntary reports. The database also lists 12 documented drug interactions derived from FDA labeling, with the top-flagged interaction rated major severity. Acquisition-cost data is surveyed weekly by CMS and updated as manufacturers report changes.
Report counts do not establish causation, a FAERS entry documents a temporal association, not proof that the drug produced the outcome. Widely prescribed medications naturally accumulate more reports than niche therapies, so raw totals must be interpreted alongside total exposure. Shortage status, recall history, and patent information are separate source-record fields. This page is a public FDA/CMS registry and does not provide medical, treatment, substitution, or medication-change directions.
Data Sources
Drug labeling: FDA Drug Labels (SPL/DailyMed). Adverse events: FDA Adverse Event Reporting System (FAERS).
FAERS reports are voluntary and do not establish causation. Drug interactions are derived from FDA labeling and clinical references. This registry does not provide medication decisions.
Last updated: November 26, 2025
PlainMeds is rendered directly from FDA openFDA/FAERS extracts, DailyMed labels, and CMS drug-pricing files, no number is typed in by an editor. FAERS counts, recalls, shortages, and price figures on this page are queried live from those federal extracts. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-05-15. Primary sources: openFDA / FAERS, DailyMed and CMS Part B ASP.
Read our methodology - how this data is sourced, computed, and verified.
Data currency: FDA FAERS adverse-event reports through 2025, CMS NADAC acquisition-cost pricing effective December 2024, compiled from the source snapshot dated . See our methodology for per-source dates and refresh cadence. Spot a figure that looks wrong? Report a data issue.
All federal data sources used on this page
- FDA Orange Book - approved drug products with therapeutic equivalence. accessdata.fda.gov/cder/ob
- FDA DailyMed - NIH-hosted drug labeling for FDA-approved meds. dailymed.nlm.nih.gov
- FDA Adverse Event Reporting System (FAERS) - post-marketing safety surveillance. fda.gov/drugs/faers
- NLM RxNorm - standardized clinical drug nomenclature. nlm.nih.gov/research/umls/rxnorm
- CMS Medicare Part B Drug Average Sales Price Files - federal drug pricing data. cms.gov/medicare/part-b-drugs/asp
- FDA Drug Shortages Database - current and resolved drug shortage tracking. accessdata.fda.gov/drugshortages